STUDY DESIGN: Four groups of 6 animals underwent single-level noninstrumented posterolateral lumbar fusion (PLF) with one of the following grafts: 1) autograft, 2) cell-enriched beta-tricalcium phosphate (TCP), 3) TCP with whole bone marrow, and 4) TCP alone. Plain radiographs were taken after surgery and at death, 6 months after surgery. Explanted spine segments were analyzed by manual palpation, micro-CT, and histology. OBJECTIVE: A sheep spine fusion study was undertaken to evaluate the healing performance of a TCP graft enriched with osteoprogenitor cells using Selective Cell Retention technology (SCR), compared with autograft, TCP with whole bone marrow, and TCP alone. SUMMARY OF BACKGROUND DATA: Improved bone healing with previously demonstrated using grafts enriched in osteoprogenitor cells. METHODS: Cell-enriched grafts were obtained by processing 30 mL of bone marrow through 10 mL of TCP. TCP was also used either saturated with bone marrow or alone. RESULTS: At 6 months, 33% of the SCR-enriched TCP and 25% of the autograft sites were fused, compared with 8% of the TCP plus whole bone marrow and 0% of the TCP alone. Histology of fused samples showed denser bone formation in the SCR-enriched TCP grafts than in the autograft sites. CONCLUSIONS: The use of SCR-enriched TCP and autograft resulted in similar fusion rates in an ovine posterolateral noninstrumented lumbar spine fusion model.
STUDY DESIGN: Four groups of 6 animals underwent single-level noninstrumented posterolateral lumbar fusion (PLF) with one of the following grafts: 1) autograft, 2) cell-enriched beta-tricalcium phosphate (TCP), 3) TCP with whole bone marrow, and 4) TCP alone. Plain radiographs were taken after surgery and at death, 6 months after surgery. Explanted spine segments were analyzed by manual palpation, micro-CT, and histology. OBJECTIVE: A sheep spine fusion study was undertaken to evaluate the healing performance of a TCP graft enriched with osteoprogenitor cells using Selective Cell Retention technology (SCR), compared with autograft, TCP with whole bone marrow, and TCP alone. SUMMARY OF BACKGROUND DATA: Improved bone healing with previously demonstrated using grafts enriched in osteoprogenitor cells. METHODS: Cell-enriched grafts were obtained by processing 30 mL of bone marrow through 10 mL of TCP. TCP was also used either saturated with bone marrow or alone. RESULTS: At 6 months, 33% of the SCR-enriched TCP and 25% of the autograft sites were fused, compared with 8% of the TCP plus whole bone marrow and 0% of the TCP alone. Histology of fused samples showed denser bone formation in the SCR-enriched TCP grafts than in the autograft sites. CONCLUSIONS: The use of SCR-enriched TCP and autograft resulted in similar fusion rates in an ovine posterolateral noninstrumented lumbar spine fusion model.
Authors: Emily M Lindley; Cameron Barton; Thomas Blount; Evalina L Burger; Christopher M J Cain; Howard B Seim; A Simon Turner; Vikas V Patel Journal: Eur Spine J Date: 2016-05-10 Impact factor: 3.134
Authors: Branko Skovrlj; Javier Z Guzman; Motasem Al Maaieh; Samuel K Cho; James C Iatridis; Sheeraz A Qureshi Journal: Spine J Date: 2014-06-11 Impact factor: 4.166
Authors: Choon G Chung; Aaron W James; Greg Asatrian; Le Chang; Alan Nguyen; Khoi Le; Georgina Bayani; Robert Lee; David Stoker; Xinli Zhang; Kang Ting; Bruno Péault; Chia Soo Journal: Stem Cells Transl Med Date: 2014-08-25 Impact factor: 6.940
Authors: Luis M Alvarez; Jaime J Rivera; Linda Stockdale; Sunil Saini; Richard T Lee; Linda G Griffith Journal: PLoS One Date: 2015-06-29 Impact factor: 3.240
Authors: María D Cuenca-López; José A Andrades; Santiago Gómez; Plácido Zamora-Navas; Enrique Guerado; Nuria Rubio; Jerónimo Blanco; José Becerra Journal: Int J Mol Sci Date: 2014-12-16 Impact factor: 5.923